493 related articles for article (PubMed ID: 25193735)
1. Statins for the Prevention of Contrast-Induced Nephropathy After Coronary Angiography/Percutaneous Interventions: A Meta-analysis of Randomized Controlled Trials.
Liu YH; Liu Y; Duan CY; Tan N; Chen JY; Zhou YL; Li LW; He PC
J Cardiovasc Pharmacol Ther; 2015 Mar; 20(2):181-92. PubMed ID: 25193735
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of short-term moderate or high-dose rosuvastatin in preventing contrast-induced nephropathy: A meta-analysis of 15 randomized controlled trials.
Liang M; Yang S; Fu N
Medicine (Baltimore); 2017 Jul; 96(27):e7384. PubMed ID: 28682890
[TBL] [Abstract][Full Text] [Related]
3. Statins and contrast-induced acute kidney injury with coronary angiography.
Gandhi S; Mosleh W; Abdel-Qadir H; Farkouh ME
Am J Med; 2014 Oct; 127(10):987-1000. PubMed ID: 24852935
[TBL] [Abstract][Full Text] [Related]
4. Short-term, high-dose Atorvastatin pretreatment to prevent contrast-induced nephropathy in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the ARMYDA-CIN [atorvastatin for reduction of myocardial damage during angioplasty--contrast-induced nephropathy] trial.
Patti G; Ricottini E; Nusca A; Colonna G; Pasceri V; D'Ambrosio A; Montinaro A; Di Sciascio G
Am J Cardiol; 2011 Jul; 108(1):1-7. PubMed ID: 21529740
[TBL] [Abstract][Full Text] [Related]
5. Impact of Chronic Statin Therapy on Postprocedural Contrast-Induced Nephropathy in Patients Undergoing Non-Emergent Percutaneous Coronary Intervention.
Chanin JM; Yang DC; Haider MA; Swaminathan RV; Kim LK; Charitakis K; Tanoue M; Minutello RM; Gade CL; Singh HS; Bergman G; Wong SC; Feldman DN
J Invasive Cardiol; 2015 Nov; 27(11):490-6. PubMed ID: 25999136
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of short-term high versus low doses of atorvastatin preventing contrast-induced acute kidney injury in patients undergoing coronary angiography/percutaneous coronary intervention.
Wu H; Li D; Fang M; Han H; Wang H
J Clin Pharmacol; 2015 Feb; 55(2):123-31. PubMed ID: 25310898
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of Short-Term Statin Treatment for the Prevention of Contrast-Induced Acute Kidney Injury in Patients Undergoing Coronary Angiography/Percutaneous Coronary Intervention: A Meta-Analysis of 21 Randomized Controlled Trials.
Li H; Wang C; Liu C; Li R; Zou M; Cheng G
Am J Cardiovasc Drugs; 2016 Jun; 16(3):201-19. PubMed ID: 26899537
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of statin pretreatment to prevent contrast-induced nephropathy and to improve long-term outcome in patients undergoing percutaneous coronary intervention.
Patti G; Nusca A; Chello M; Pasceri V; D'Ambrosio A; Vetrovec GW; Di Sciascio G
Am J Cardiol; 2008 Feb; 101(3):279-85. PubMed ID: 18237585
[TBL] [Abstract][Full Text] [Related]
9. Statins for prevention of contrast-induced nephropathy in patients undergoing non-emergent percutaneous coronary intervention.
Kandula P; Shah R; Singh N; Markwell SJ; Bhensdadia N; Navaneethan SD
Nephrology (Carlton); 2010 Mar; 15(2):165-70. PubMed ID: 20470274
[TBL] [Abstract][Full Text] [Related]
10. Uric acid levels and the risk of Contrast Induced Nephropathy in patients undergoing coronary angiography or PCI.
Barbieri L; Verdoia M; Schaffer A; Cassetti E; Marino P; Suryapranata H; De Luca G;
Nutr Metab Cardiovasc Dis; 2015 Feb; 25(2):181-6. PubMed ID: 25315668
[TBL] [Abstract][Full Text] [Related]
11. High-dose statin pretreatment for the prevention of contrast-induced nephropathy: a meta-analysis.
Zhang BC; Li WM; Xu YW
Can J Cardiol; 2011; 27(6):851-8. PubMed ID: 21944277
[TBL] [Abstract][Full Text] [Related]
12. Effect of statins in preventing contrast-induced nephropathy: an updated meta-analysis.
Xie H; Ye Y; Shan G; Zhang S; Fang Q; Yang D; Zeng Y
Coron Artery Dis; 2014 Nov; 25(7):565-74. PubMed ID: 25036858
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of statin pretreatment for the prevention of contrast-induced nephropathy: a meta-analysis of randomised controlled trials.
Zhang L; Zhang L; Lu Y; Wu B; Zhang S; Jiang H; Ge J; Chen H
Int J Clin Pract; 2011 May; 65(5):624-30. PubMed ID: 21489086
[TBL] [Abstract][Full Text] [Related]
14. 3-Hydroxy-3-methylglutaryl-CoA reductase enzyme inhibitors for prevention of contrast-induced nephropathy: a meta-analysis of prospective randomized controlled studies.
Briasoulis A; Mallikethi-Reddy S; Sharma S; Briasouli AA; Afonso L
Am J Ther; 2015; 22(6):e158-66. PubMed ID: 25187093
[TBL] [Abstract][Full Text] [Related]
15. Statin therapy reduces contrast-induced nephropathy: an analysis of contemporary percutaneous interventions.
Khanal S; Attallah N; Smith DE; Kline-Rogers E; Share D; O'Donnell MJ; Moscucci M
Am J Med; 2005 Aug; 118(8):843-9. PubMed ID: 16084176
[TBL] [Abstract][Full Text] [Related]
16. Comparative efficacy of pharmacological interventions for contrast-induced nephropathy prevention after coronary angiography: a network meta-analysis from randomized trials.
Ma WQ; Zhao Y; Wang Y; Han XQ; Zhu Y; Liu NF
Int Urol Nephrol; 2018 Jun; 50(6):1085-1095. PubMed ID: 29404930
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic atorvastatin prior to intra-arterial administration of iodinated contrast media for prevention of contrast-induced acute kidney injury: A meta-analysis of randomized trial data
.
Sun YY; Liu LY; Sun T; Wu MY; Ma FZ
Clin Nephrol; 2019 Sep; 92(3):123-130. PubMed ID: 31347493
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of short-term moderate or high-dose statin therapy for the prevention of contrast-induced nephropathy in high-risk patients with chronic kidney disease: systematic review and meta-analysis.
Zhou YL; Chen LQ; Du XG
Clinics (Sao Paulo); 2021; 76():e1876. PubMed ID: 33787670
[TBL] [Abstract][Full Text] [Related]
19. Impact of high loading dose of atorvastatin in diabetic patients with renal dysfunction undergoing elective percutaneous coronary intervention: a randomized controlled trial.
Shehata M; Hamza M
Cardiovasc Ther; 2015 Apr; 33(2):35-41. PubMed ID: 25677920
[TBL] [Abstract][Full Text] [Related]
20. The role of statins in the prevention of contrast induced nephropathy: a meta-analysis of 8 randomized trials.
Barbieri L; Verdoia M; Schaffer A; Nardin M; Marino P; De Luca G
J Thromb Thrombolysis; 2014 Nov; 38(4):493-502. PubMed ID: 24705677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
